$64.78 0%
Price vs. AI Score (Last 150 days)
Data gathered: December 4

Data Bits

Data Bits Value / Change Benchmark
Job Posts 1,700 0%
Sentiment 94 0%
Webpage traffic 728,000 11.6%
Customer reviews N/A N/A
Employee Rating 82 0%
Google Adspend $5,678 122.8% N/A
Google Trends 21 -48.8%
Linkedin Employees 67,422 N/A
Lobbying Cost $380,000 0%
NPS 23 -4.2%
Patents 0%
4chan Mentions 0%
Facebook Engagement 105 -0.9%
Facebook followers 57,760 0%
Stocktwits Mentions 6 -14.3%
Stocktwits Subscribers 18,279 0%
Twitter Followers 303,209 -0%
Youtube Subscribers 13,900 0%
Instagram Followers 67,628 0%
News Mentions 2 -87.5%
Reddit Mentions 0%
Business outlook 81 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Astrazeneca

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Price $64.78
Target Price Sign up
Market Cap $201B
Dividend Yield 0.0224
Industry Drug Manufacturers

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2311.5B2.1B9.4B1.37B3.33B
Q2 '2311.4B1.96B9.46B1.82B2.52B
Q1 '2310.9B1.91B8.97B1.8B3.89B
Q4 '2211.2B2.9B8.31B901M1.14B
Q3 '2211B2.98B8B1.64B2.76B
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.